Curative Biotechnology Inc (CUBT) — Cash Flow Reinvestment Rate

Latest as of December 2022: 0.00x

Curative Biotechnology Inc (CUBT) has a Cash Flow Reinvestment Rate of 0.00x as of December 2022, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $135.81K. See Curative Biotechnology Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$0.00
Capex + Investments

Operating Cash Flow

$135.81K
USD

Capital Expenditures

$0.00
USD

Curative Biotechnology Inc Cash Flow Reinvestment Rate (2015–2015)

Historical reinvestment intensity for Curative Biotechnology Inc across 1 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Curative Biotechnology Inc.

Annual Cash Flow Reinvestment Rate for Curative Biotechnology Inc (2015–2015)

Year-by-year capital reinvestment analysis for Curative Biotechnology Inc. See Curative Biotechnology Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2015 0.00x $0.00 $1.96K $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow